[1]
“INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES”, RMSR, vol. 3, no. 4, pp. 307–312, Apr. 2025, Accessed: May 11, 2025. [Online]. Available: http://thermsr.com/index.php/Journal/article/view/929